
Cuban health authorities have begun a clinical trial of the drug Jusvinza, developed by the Center for Genetic Engineering and Biotechnology, to treat residual polyarthritis in patients recovering from Chikungunya, the Biocubafarma Group announced on its Facebook profile.
Read more Cuba conducts clinical trial of Jusvinza for treating Chikungunya

Cuba’s scientific expertise in treating autoimmune diseases was showcased at the plenary session of the 19th International Congress of Immunology, taking place in Vienna until August 22.
Read more Cuban biotechnology stands out at World Immunology CongressFrancisco Durán, national director of Hygiene and Epidemiology, informed in a press conference that there is still a spate of viral infections in the country caused mainly by dengue fever, with increased incidence in the western and central provinces.
Read more Arboviral illnesses still spreading in Cuba
he second day of sessions of the standing working committees of the National Assembly of People's Power began today in Havana with an analysis of the progress of the housing program attended by President Miguel Diaz-Canel.
Read more Diaz-Canel attends parliamentary debate on housing program
Page 327 of 498